Skip to main content

Alba Torrent Vernetta

Institutions of which they are part

Predoctoral researcher
Growth and Development
Vall Hebron Institut de Recerca

Alba Torrent Vernetta

Institutions of which they are part

Predoctoral researcher
Growth and Development
Vall Hebron Institut de Recerca

Projects

Creixement i Desenvolupament

IP: Antonio Moreno Galdó
Collaborators: Maria Clemente Leon, Diego Yeste Fernandez, Félix Castillo Salinas, elena sena , Inés de Mir Messa, Ariadna Campos Martorell, Sandra Rovira Amigo, Alba Torrent Vernetta, Ana Díez Izquierdo, Noelia Baz Redón, Nuria Camats Tarruella, SILVIA GARTNER TIZZANO
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 00779
Duration: 01/01/2022 - 31/12/2024

Primary ciliary dyskinesia in adult bronchiectasis. Diagnostic strategy based on next generation sequencing gene panel analysis.

IP: Antonio Moreno Galdó
Collaborators: Antonio Álvarez Fernandez, David Clofent Alarcón, Sandra Rovira Amigo, Alba Torrent Vernetta, Noelia Baz Redón, Nuria Camats Tarruella
Funding agency: Instituto de Salud Carlos III
Funding: 134915
Reference: PI20/01419
Duration: 01/01/2021 - 30/06/2025

HCQ4Surfdefect: Repurposing hydroxychloroquine for treatment of surfactant dysfunction disorders

IP: Antonio Moreno Galdó
Collaborators: Inés de Mir Messa, Sandra Rovira Amigo, Alba Torrent Vernetta, SILVIA GARTNER TIZZANO
Funding agency: Instituto de Salud Carlos III
Funding: 96105.46
Reference: AC16/00027
Duration: 01/01/2017 - 30/11/2020

Efecto de la suplementación con vitamina D en la prevención de las bronquitis agudas durante el primer año de vida

IP: Antonio Moreno Galdó
Collaborators: Antonio Carrascosa Lezcano, Roser Ferrer Costa, Alba Torrent Vernetta
Funding agency: Ministerio Sanidad
Funding: 148410
Reference: EC11-476
Duration: 01/01/2012 - 31/10/2017

Related news

Es va reconèixer la tasca de més de 70 professionals dedicades a aquesta malaltia pulmonar, tant assistencial com de recerca.

The two studies awarded has been the research for a the ciliary dyskinesia diagnosis led by the VHIR’s Growth and Development Group and the EPISCAN II, in which Dr. Miravitlles has participated.

An international clinical trial has demonstrated the effectiveness of dupilumab in reducing patients’ asthmatic exacerbations, improving their and their relatives quality of life

Related professionals

Joan Pijoan Bueno

Joan Pijoan Bueno

Predoctoral researcher
Reconstructive Surgery of the Locomotor System
Read more
Laia Perez Lasarte

Laia Perez Lasarte

Head of unit
Employment Relations Unit
Human Resources and Lega Area
Read more
Sofia Alonso Mateos

Sofia Alonso Mateos

Research technician
Transfusional Medicine
Read more
Alexandre Rue Jimenez

Alexandre Rue Jimenez

Research technician
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.